A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
Jens Overgaard, Hanne Sand Hansen(Rigshospitalet), Marie Overgaard(Aarhus University Hospital), Lars Bastholt(Odense University Hospital), Anne Berthelsen(Herlev Hospital), Lena Specht(Herlev Hospital), Birgit Lindeløv(Rigshospitalet), Karsten Juhl Jørgensen(Odense University Hospital)
Cited by 567
Abstract
Related Papers
No related papers found
Powered by citation graph analysis